150 related articles for article (PubMed ID: 33407647)
1. Postoperative radiotherapy is associated with improved survival in pT1-2N1 oral and oropharyngeal cancer without adequate neck dissection.
Yang CC; Kang BH; Liu WS; Yin CH; Lee CC
Radiat Oncol; 2021 Jan; 16(1):6. PubMed ID: 33407647
[TBL] [Abstract][Full Text] [Related]
2. The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx.
O'Brien CJ; Traynor SJ; McNeil E; McMahon JD; Chaplin JM
Arch Otolaryngol Head Neck Surg; 2000 Mar; 126(3):360-5. PubMed ID: 10722009
[TBL] [Abstract][Full Text] [Related]
3. Lymph node yield from neck dissection in HPV-associated oropharyngeal cancer.
Zenga J; Stadler M; Massey B; Campbell B; Shukla M; Awan M; Schultz CJ; Wong S; Jackson RS; Pipkorn P
Laryngoscope; 2020 Mar; 130(3):666-671. PubMed ID: 31206708
[TBL] [Abstract][Full Text] [Related]
4. The Benefit of Postoperative Radiotherapy and Extending Neck Dissection in pT1-2 Oral Squamous Cell Carcinoma With a Single Ipsilateral Cervical Lymph Node Metastasis (pN1).
Alsharif U; Steller D; Falougy M; Tharun L; Rades D; Hakim SG
Anticancer Res; 2022 Jan; 42(1):97-104. PubMed ID: 34969714
[TBL] [Abstract][Full Text] [Related]
5. A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial.
Biau J; Thivat E; Millardet C; Saroul N; Pham-Dang N; Molnar I; Pereira B; Durando X; Bourhis J; Lapeyre M
BMC Cancer; 2020 Aug; 20(1):730. PubMed ID: 32758188
[TBL] [Abstract][Full Text] [Related]
6. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI;
Cochrane Database Syst Rev; 2010 Sep; (9):CD006386. PubMed ID: 20824847
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors influencing contralateral neck lymph node metastases in oral and oropharyngeal carcinoma.
Capote-Moreno A; Naval L; Muñoz-Guerra MF; Sastre J; Rodríguez-Campo FJ
J Oral Maxillofac Surg; 2010 Feb; 68(2):268-75. PubMed ID: 20116694
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Mortality in HPV-Associated Oropharynx Carcinoma Treated With Surgery Alone.
Han M; Stanford-Moore GB; Larson AR; Schoppy DW; Cognetti DM; Joshi AS; Houlton JJ; Ryan WR
Laryngoscope; 2020 Jul; 130(7):E423-E435. PubMed ID: 31675132
[TBL] [Abstract][Full Text] [Related]
9. Modified neck dissection. A study of 967 cases from 1970 to 1980.
Byers RM
Am J Surg; 1985 Oct; 150(4):414-21. PubMed ID: 4051103
[TBL] [Abstract][Full Text] [Related]
10. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
[TBL] [Abstract][Full Text] [Related]
11. The impact of extranodal spread of lymph node metastases in patients with oral cancer.
Shingaki S; Nomura T; Takada M; Kobayashi T; Suzuki I; Nakajima T
Int J Oral Maxillofac Surg; 1999 Aug; 28(4):279-84. PubMed ID: 10416895
[TBL] [Abstract][Full Text] [Related]
12. Results of surgical treatment of T3 and T4 tumors of the oral cavity and oropharynx.
Pinsolle J; Demeaux H; Coustal B; Siberchicot F; Caudry M; Maire JP; Michelet FX
Am J Surg; 1992 Dec; 164(6):587-91. PubMed ID: 1463105
[TBL] [Abstract][Full Text] [Related]
13. Ipsilateral irradiation for oral and oropharyngeal carcinoma treated with primary surgery and postoperative radiotherapy.
Vergeer MR; Doornaert PA; Jonkman A; Kaanders JH; van den Ende PL; de Jong MA; Leemans CR; Slotman BJ; Langendijk JA
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):682-8. PubMed ID: 20188492
[TBL] [Abstract][Full Text] [Related]
14. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
[TBL] [Abstract][Full Text] [Related]
15. Identification of a high-risk group among patients with oral cavity squamous cell carcinoma and pT1-2N0 disease.
Liao CT; Lin CY; Fan KH; Wang HM; Ng SH; Lee LY; Hsueh C; Chen IH; Huang SF; Kang CJ; Yen TC
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):284-90. PubMed ID: 21075550
[TBL] [Abstract][Full Text] [Related]
16. Elective neck dissection vs observation in transorally treated early head and neck carcinomas with cN0 neck.
Psychogios G; Mantsopoulos K; Koch M; Klintworth N; Kapsreiter M; Zenk J; Iro H
Acta Otolaryngol; 2013 Mar; 133(3):313-7. PubMed ID: 23294240
[TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis of adjuvant radiotherapy in oral cavity or oropharyngeal cancer: Feasibility of omitting lower-neck irradiation.
Ho SY; Kao WC; Hsiao SY; Chiu SF; Lee SW; Chen JC; Shieh LT
PLoS One; 2022; 17(4):e0266678. PubMed ID: 35404969
[TBL] [Abstract][Full Text] [Related]
18. Association of Postoperative Radiotherapy With Survival in Patients With N1 Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
Chen MM; Harris JP; Hara W; Sirjani D; Divi V
JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1224-1230. PubMed ID: 27832255
[TBL] [Abstract][Full Text] [Related]
19. Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer.
McMahon J; O'Brien CJ; Pathak I; Hamill R; McNeil E; Hammersley N; Gardiner S; Junor E
Br J Oral Maxillofac Surg; 2003 Aug; 41(4):224-31. PubMed ID: 12946663
[TBL] [Abstract][Full Text] [Related]
20. Utilization and Survival of Postoperative Radiation or Chemoradiation for pT1-2N1M0 Head and Neck Cancer.
Lee A; Givi B; Roden DF; Tam MM; Wu SP; Gerber NK; Hu KS; Schreiber D
Otolaryngol Head Neck Surg; 2018 Apr; 158(4):677-684. PubMed ID: 29256329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
